Neuronetics Reports Strong Q4 2025 Revenue Growth and Achieves Positive Operating Cash Flow
STIM sits 65% above its 52-week low of $1.25 on elevated volume (3.2× avg).
Summary
Neuronetics, Inc. reported preliminary Q4 2025 revenue of $41.8 million, marking 86% year-over-year growth, and achieved positive operating cash flow of $0.9 million, ending the year with $34.1 million in cash.
Key Events · Earnings and Guidance · STIM
-
Strong Fourth Quarter Revenue Growth
Reported preliminary unaudited Q4 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as-reported basis and 23% year-over-year growth on an adjusted pro forma basis.
-
Full Year Revenue Exceeds Expectations
Achieved preliminary unaudited full year 2025 revenue of $149.2 million, a 99% increase year-over-year as reported and 15% increase on an adjusted pro forma basis.
-
Positive Operating Cash Flow
Generated positive operating cash flow of $0.9 million in the fourth quarter of 2025, a significant financial milestone.
-
Healthy Cash Position
Ended 2025 with a total cash balance of $34.1 million, inclusive of cash, cash equivalents, and restricted cash.
Analysis · STIM · Industrial Applications And Services
Neuronetics, Inc. announced preliminary unaudited financial results for the fourth quarter and full year 2025, demonstrating significant commercial execution and improved financial health. The company achieved substantial revenue growth, both on an as-reported and adjusted pro forma basis, indicating strong performance following the Greenbrook acquisition. Critically, Neuronetics generated positive operating cash flow in Q4 2025, a key milestone that suggests improved operational efficiency and financial stability. The healthy cash balance at year-end further strengthens its position as it moves into 2026. These results provide a positive outlook for the company's ability to execute its strategy and manage its financial runway.
At the time of this filing, STIM was trading at $2.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $100M. The 52-week trading range was $1.25 to $5.92. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.